IRIS
Grimaldi, Luigi Maria Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.560
AS - Asia 3.507
SA - Sud America 1.264
EU - Europa 489
AF - Africa 170
OC - Oceania 4
Totale 8.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.274
SG - Singapore 1.224
BR - Brasile 953
CN - Cina 639
BD - Bangladesh 428
HK - Hong Kong 337
VN - Vietnam 258
IT - Italia 242
IN - India 115
MX - Messico 115
CA - Canada 109
AR - Argentina 91
IQ - Iraq 85
CO - Colombia 69
ID - Indonesia 58
TR - Turchia 54
PK - Pakistan 50
ZA - Sudafrica 50
EC - Ecuador 49
SA - Arabia Saudita 44
GB - Regno Unito 39
VE - Venezuela 39
FR - Francia 36
RU - Federazione Russa 36
PH - Filippine 34
UZ - Uzbekistan 32
DE - Germania 31
MA - Marocco 25
CL - Cile 23
UA - Ucraina 22
TN - Tunisia 18
JM - Giamaica 17
KE - Kenya 17
MY - Malesia 17
AE - Emirati Arabi Uniti 14
JO - Giordania 14
PY - Paraguay 14
NP - Nepal 13
PE - Perù 13
EG - Egitto 12
ES - Italia 12
ET - Etiopia 11
NL - Olanda 11
TH - Thailandia 11
AL - Albania 10
CR - Costa Rica 9
OM - Oman 8
AZ - Azerbaigian 7
BO - Bolivia 7
SV - El Salvador 7
DZ - Algeria 6
JP - Giappone 6
LB - Libano 6
PS - Palestinian Territory 6
RS - Serbia 6
HU - Ungheria 5
IE - Irlanda 5
IL - Israele 5
MU - Mauritius 5
BG - Bulgaria 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
KZ - Kazakistan 4
PA - Panama 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AM - Armenia 3
AU - Australia 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
HN - Honduras 3
LY - Libia 3
NI - Nicaragua 3
PL - Polonia 3
QA - Qatar 3
RE - Reunion 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
IR - Iran 2
KH - Cambogia 2
KN - Saint Kitts e Nevis 2
KR - Corea 2
LK - Sri Lanka 2
NO - Norvegia 2
PT - Portogallo 2
SE - Svezia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
UG - Uganda 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
Totale 8.963
Salva come PNG Salva come JPEG
Città #
San Jose 1.756
Singapore 601
Ashburn 575
Beijing 344
Hong Kong 329
Ho Chi Minh City 96
Mexico City 92
Santa Clara 85
New York 76
São Paulo 70
Hanoi 48
Rome 41
Rio de Janeiro 39
Baghdad 34
Los Angeles 31
Milan 30
Tashkent 29
Chicago 21
Istanbul 20
Quito 20
Curitiba 19
Medellín 19
Brasília 18
Haiphong 17
Lahore 17
Belo Horizonte 16
Cape Town 16
Bogotá 15
Buffalo 15
Caracas 15
Council Bluffs 15
Dallas 15
Dhaka 15
Porto Alegre 15
Guayaquil 14
Kingston 14
Nairobi 14
Naples 14
Toronto 14
Atlanta 13
Campinas 13
Guarulhos 13
Da Nang 12
Montreal 12
Recife 12
Riyadh 12
Jeddah 11
Frankfurt am Main 10
Goiânia 10
Houston 10
Addis Ababa 9
Jakarta 9
Johannesburg 9
Lima 9
Nova Iguaçu 9
Salvador 9
Santiago 9
Amman 8
Asunción 8
Biên Hòa 8
Brooklyn 8
Casablanca 8
Caxias do Sul 8
Dammam 8
Delhi 8
Manaus 8
Mumbai 8
Ottawa 8
Pune 8
Secaucus 8
Toledo 8
Figino 7
Hải Dương 7
Karachi 7
Las Vegas 7
Memphis 7
Newark 7
Palermo 7
San Salvador 7
Valencia 7
Baku 6
Baton Rouge 6
Cleveland 6
Detroit 6
Durban 6
Florence 6
Indianapolis 6
Kathmandu 6
Kuala Lumpur 6
Maricá 6
Medina 6
Milwaukee 6
Muscat 6
Ourinhos 6
Philadelphia 6
Queens 6
Rabat 6
Ribeirão Preto 6
San José 6
Shanghai 6
Totale 5.120
Salva come PNG Salva come JPEG
Nome #
Cytokines and immunity in multiple sclerosis: The dual signal hypothesis 186
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: Report from the Italian Multiple Sclerosis Study group 80
Induction of IL-1 receptor antagonist by interferon beta: Implication for the treatment of multiple sclerosis 76
Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors 71
Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: Relation to insulin-dependent diabetes mellitus and islet cell antibodies 63
An isoelectric focusing study in herpes simplex virus encephalitis 60
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 60
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 60
The fate of human peripheral blood lymphocytes after transplantation into SCID mice 58
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymerc mixture, in patients with relapsing-remitting multiple sclerosis 56
Multiple Sclerosis Progression and Relapse Activity in Children 54
Rivastigmine may be helpful for the dementia of Parkinson's disease 52
Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease 52
The role of IL-1 gene cluster in longevity: A study in Italian population 52
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective 51
The Italian multiple sclerosis register 50
The italian pharmacovigilance program: An observational study of adverse effects of natalizumab in multiple sclerosis therapy 48
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 45
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 44
Natalizumab in the pediatric MS population: Results of the Italian registry 44
INTERFERON CALCIUM PATIENTS CLINICAL ACTIVE LESIONS ON MRI (IFN)-y-INDUCED INTRACELLULAR T LYMPHOCYTES FROM PATIENTS WITH MULTIPLE SCLEROSIS PRECEDES CLINICAL EXACERBATION AND DETECTION OF ACTIVE LESIONS ON MRI 43
Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype 43
Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease 43
γ Interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis 42
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 41
Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis 41
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial 41
Intracellular Ca2+ stores of T lymphocytes: Changes induced by in vitro and in vivo activation 40
18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification 40
A novel missense mutation (L219F) in exon 8 of the preselinin 1 gene in an Italian family with presenile familial Alzheimer's disease 39
Interferon-γ activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis 38
An Italian programme for COVID-19 infection in multiple sclerosis 37
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study 37
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 37
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 37
Absence of IgG, IgA or IgM oligoclonal bands in tears from multiple sclerosis patients 36
Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α 36
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension 36
Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis 36
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 36
Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register 35
Multiple sclerosis in children under 6 years of age 35
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 35
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 34
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 34
An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients 34
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis 34
Light chain composition of CSF and sera oligoclonal IgG bands in asymptomatic HIV seropositive (AHS) and AIDS patients with central nervous system (CNS) involvement 34
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study 34
Guidelines for the diagnosis of dementia and Alzheimer's disease. The Dementia Study Group of the Italian Neurological Society 33
Genetic heterogeneity in Italian families with familial hemiplegic migraine 33
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population 33
Oligoclonal IgA bands in multiple sclerosis and subacute sclerosing panencephalitis 33
Association study of two APOE polymorphisms in Italian MS patients 33
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial 33
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study 33
Association of early onset Alzheimer's disease with an interleukin-1 α polymorphism 32
HTLV-I-associated myelopathy: Oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody 32
Absence of engraftment of lymphoid organs in hu-PBL SCID mice: a study employing fluorescent in situ hybridization (FISH) for the identification of human cells 32
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 32
Il contributo della genetica alla prognosi delle malattie neurologiche 32
Assessment of brain core temperature using MR DWI-thermometry in Alzheimer disease patients compared to healthy subjects 32
Signs and symptoms of COVID-19 in patients with multiple sclerosis 32
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 32
Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse 32
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification 31
A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects 31
Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain 31
A chimeric human/mouse model for studying myasthenia gravis 31
Discontinuous distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients 31
An immunovirological study of central nervous system involvement during HIV-1 infection of chimpanzees 31
Genetic burden of common variants in progressive and bout-onset multiple sclerosis 31
Vigabatrin improves rigidity in Stiff-person syndrome (SPS) 31
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk 31
Multiple sclerosis in children under 10 years of age 31
Immunità e flogosi nella malattia di Alzheimer 31
A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease 31
Cholesterol abnormalities in a cohort of Sicilian patients with multiple sclerosis 31
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population 31
Search for candidate genes in common migraine in the Italian population 30
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 30
The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome in patients 30
A γ-interferon-activated Ca2+ influx in T-lymphocytes from multiple sclerosis patients influences immune activation during disease exacerbation 30
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 30
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with alzheimers disease: A prospective, observational study 30
Catene leggere kappa e lambda e α-TNF in pazienti con infezione da HIV 30
Interferon (IFN)-Y-induced intracellular calcium increase in T lymphocytes from patfents with multiple sclerosis precedes clinical exacerbation and detection of active lesions on MRI 30
High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy 30
Improved conditions for the analysis of large variable number of tandemly repeated (VNTR) unit polymorphisms 30
Longitudinal changes in social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II) 30
A SCID mouse model of myasthenia gravis: pathological and serological findings 30
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study 30
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study 30
The molecular anatomy of human Hps60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential patogenetic role of anti-chaperonin immunity in myasthenia gravis 30
Efficacy of vitamin D 3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, doubble-blind, randomized, placebo-controlled trial 30
Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients 30
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 30
Relevance of an intronic polymorphism in myasthenia gravis: a preliminary study 30
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 30
Analysis of an IFN-γ gene (IFNG) polymorphism in multiple sclerosis in Europe: Effect of population structure on association with disease 29
Totale 3.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.694 0 0 0 0 0 0 54 151 135 163 530 661
2025/20267.424 354 48 404 561 734 450 689 347 1.674 986 465 712
2026/2027223 223 0 0 0 0 0 0 0 0 0 0 0
Totale 9.341